- Home
- GALT vs ATLX Comparison
GALT vs ATLX Comparison
Compare GALT & ATLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- ATLX
- Stock Information
- Founded
- GALT 2000
- ATLX 2011
- Country
- GALT United States
- ATLX Brazil
- Employees
- GALT N/A
- ATLX N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- GALT Health Care
- ATLX Industrials
- Exchange
- GALT Nasdaq
- ATLX Nasdaq
- Market Cap
- GALT 83.5M
- ATLX 68.5M
- IPO Year
- GALT N/A
- ATLX N/A
- Fundamental
- Price
- GALT $2.80
- ATLX $3.96
- Analyst Decision
- GALT Buy
- ATLX Strong Buy
- Analyst Count
- GALT 2
- ATLX 2
- Target Price
- GALT $6.00
- ATLX $22.25
- AVG Volume (30 Days)
- GALT 1.5M
- ATLX 253.0K
- Earning Date
- GALT 08-12-2025
- ATLX 08-08-2025
- Dividend Yield
- GALT N/A
- ATLX N/A
- EPS Growth
- GALT N/A
- ATLX N/A
- EPS
- GALT N/A
- ATLX N/A
- Revenue
- GALT N/A
- ATLX $587,122.00
- Revenue This Year
- GALT N/A
- ATLX $19,668.81
- Revenue Next Year
- GALT N/A
- ATLX $43.15
- P/E Ratio
- GALT N/A
- ATLX N/A
- Revenue Growth
- GALT N/A
- ATLX 214.46
- 52 Week Low
- GALT $0.73
- ATLX $3.54
- 52 Week High
- GALT $3.90
- ATLX $13.70
- Technical
- Relative Strength Index (RSI)
- GALT 67.38
- ATLX 49.43
- Support Level
- GALT $2.07
- ATLX $3.92
- Resistance Level
- GALT $2.36
- ATLX $4.25
- Average True Range (ATR)
- GALT 0.24
- ATLX 0.22
- MACD
- GALT 0.03
- ATLX 0.02
- Stochastic Oscillator
- GALT 81.11
- ATLX 63.91
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.